Table 2 Demographic data of patients affected with different EVs in this study
Demographic data | |||||
|---|---|---|---|---|---|
EV serotypes | All | CVA-6 | CVA-10 | CVA-16 | Othersa |
Total number of patients | N = 1220 | N = 364 | N = 305 | N = 397 | N = 154 |
Sex | |||||
 Male | 712(58.4%) | 223(18.3%) | 155 (12.7%) | 229 (18.8%) | 105(8.6%) |
 Female | 508(41.6%) | 141(11.6%) | 150(12.3%) | 168 (13.8%) | 49(4.0%) |
Age range (years) | |||||
  < 1 | 164 (13.4%) | 56(4.6%) | 36(3.0%) | 39(3.2%) | 33(2.7%) |
 1–3 | 656(53.8%) | 218(17.9%) | 173(14.2%) | 182 (14.9%) | 83(6.8%) |
 3–5 | 332(27.2%) | 64(5.2%) | 87(7.1%) | 145(11.9%) | 36(3.0%) |
  > 5 | 68(5.6%) | 26(2.1%) | 9(0.7%) | 31(2.5%) | 2(0.2%) |